Privo Technologies Is A Privately Fundedphase Iii Oncology Company That Spun Out Of The World Renowned Langer Laboratory At The Massachusetts Institute Of Technologymitin Cambridgemassachusettsusaprivo Is Developing A Novelnanotechnology Based Drug Delivery Platform Capable Of Local And Systemic Delivery Of A Constantcontrolled Therapeutic Dose Through The Mucosathis Approach Eliminates Needlesavoids Stomach Acidscan Significantly Reduce Toxic Side Effects Of Drugs And Allows For Higher Dosing Where The Drugs Can Be Most Effective Aeall Of Which Improve Patient Outcomes And Compliance Privo Was Founded By Manijeh Goldberg Who Is A Seasoned Executive With Over 25 Years Of Experience In The Medical Industry As An Executive Leader And A Scientist In Large And Small Start Up Companiesone Of Whichepiconwas Acquired For $475Mher 12 Years Of Large Company Experience Includes Working For Hp Medical And Siemens Medical Systemsmanijeh S Mba From Mit And Ms From Harvard Medical School Led To Her Working With Professor Robert Langerprofessor Langer Has Global Expertise In Nanotechnology And Drug Delivery And Is Now An Advisor To Privo Privo Is Focused On Dramatically Improving Human Health Through Its Novel And Proprietary Mucosal Delivery Particlemdpplatformprivo S Platform Has Both Small And Large Molecule Applicationsthe Technologies Used In Privo S Platform Have Won Awards And Significant Grants From The Fda And Nih
No conferences found for this company.
| Company Name | Privo Technologies Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
